WHO Issues Bird Flu Warning in Europe After First H9N2 Import Case in Italy
The World Health Organization has issued urgent guidance following the diagnosis of a man with the H9N2 bird flu strain in Italy. This case represents the first time this particular subtype has been imported into Europe, raising significant concerns among health authorities about a potential new public health crisis.
Details of the Imported Infection
The patient, an adult male, had recently returned to Italy after spending six months in Senegal. Upon arrival, he presented at an emergency department with symptoms including a fever and a persistent cough. Medical tests confirmed he was infected with the A(H9N2) avian influenza virus, a strain previously not documented within European borders.
Complicating his condition further, additional tests revealed the patient was also battling tuberculosis. He was immediately placed in a negative-pressure isolation room as healthcare professionals worked to contain any potential spread of the virus.
WHO Guidance and Risk Assessment
In response to this development, the WHO has released specific recommendations to mitigate risks. The organization currently assesses the overall risk to the general population as low. However, they emphasize that any human infection caused by a novel influenza A virus subtype carries the potential for high public health impact and must be reported under International Health Regulations.
The public guidance includes:
- Avoiding contact with high-risk environments such as live animal markets, farms, or surfaces potentially contaminated by poultry faeces.
- Using respiratory protection for individuals handling live or dead poultry in occupational or backyard-farming settings.
- Maintaining good hand hygiene through frequent washing or use of alcohol-based sanitisers.
Investigation and Surveillance Measures
The case has presented investigators with a puzzling element: the patient reported no known history of exposure to poultry or contact with infected individuals prior to falling ill. Preliminary genetic analysis suggests the infection was most likely contracted from an avian source in Senegal, where the virus circulates among bird populations.
As a precautionary measure, close contacts of the patient in both Italy and Senegal have been identified, placed under surveillance, and some have received preventive antiviral medication. This proactive approach aims to prevent any potential outbreak from gaining momentum.
Symptoms and Ongoing Monitoring
Health experts caution that the H9N2 bird flu strain can trigger a range of symptoms in humans, from mild respiratory issues to severe illness. Potential complications include conjunctivitis, gastrointestinal pain, encephalitis (brain swelling), and in some cases, death.
While the patient remains in stable condition, the WHO continues to monitor the situation globally. The organization maintains that the likelihood of human-to-human transmission is low but stresses the importance of vigilance as the threat persists across Europe.
